• Advising and acting for an American global pharmaceutical company in relation to patent issues relating to a number of the companies' products. This included acting for the company in multiple proceedings in Australia and co-ordinating proceedings in Singapore as part of a global team involved in multi-jurisdictional patent infringement and revocation proceedings with respect to a family of patents relating to the company's successful anti-cancer treatment product, a nucleoside analogue. In the main Australian proceedings, the company successfully resisted a challenge to the patent term extension of one of the patents-in-suit, successfully amended the claims of that patent in the course of litigation and successfully obtained an interlocutory (preliminary) injunction enjoining the marketing of two generic competitor's products. The proceedings established an important set of guiding principles in Australia for determining when an interlocutory injunction will be granted in pharmaceutical patent infringement cases
  • Advising one of the world's top multinational pharmaceutical companies on patent - including patent term extension, patent portfolio management and patent litigation - and non-patent (including data exclusivity) strategies to maximise the commercial life of its product portfolio
  • Advising the world leader in implantable hearing solutions on a number of patent issues regarding a family of electrical and mechanical engineering patents in the field of hearing aids and hearing implants
  • Advising and negotiating on behalf of a leading biotechnology company in relation to the licensing of a family of RNAi patents
  • Acting for one of the world's premier veterinary pharmaceutical companies in an appeal from the decision of the Australian Patent Office relating to a patent directed to an equine anthelmintic formulation
  • Acting for eight of the world's leading manufacturers of bar code scanning technology and one of the world's leading manufacturers of computer vision technology in a patent infringement action brought by a US inventor in relation to a family of patents directed to bar code scanning and machine vision technology. The case, which was appealed to the United States Supreme Court, established an important new defence to patent infringement
  • Advising global financial institution in relation to a number of business method patents for the financial services industry